Bold Stocks

VANCOUVER, BRITISH COLUMBIA - Eternity Healthcare Inc. (OTCBB:ETAH) (the “Company”), a medical device company, is pleased to announce today a major development in medical technologies. The Company introduces a new device that has ability to measure total cholesterol from a drop of blood. It takes approximately between 2-3 minutes to get highly accurate level of cholesterol in the blood. The device has further ability to measure the glucose level and the triglycerides. This multifunctional device will require to obtain regulatory approvals in North America by FDA or others before marketing. The process for the approval has initiated. The device is designed to be used primarily at home and at doctor’s office by professionals and non-professionals.

About Eternity Healthcare

Eternity Healthcare is a publically listed company in the United States under the stock symbol of “ETAH”. The Company is the leader in medical technologies with state of the art medical devices, including diagnostic kits, digital cholesterol readers, injection free needles and more. For further information visit the Company’s website: www.eternityhealthcare.com.

Notice Regarding Forward Looking Statements

This press release includes forward-looking statements that involve a number of risks and uncertainties, including the success of the products in commercializing and developing. Further, the risks involve the ability of the Company to raise capital to fund its operations and the capital requirements for the development and marketing of its products. Investors are encouraged to review the risk factors listed or described from time to time in the Company’s filings (10K) with the Securities and Exchange Commission.